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743 Eugene Braunwald, MD(continued on page 12A
The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 4 11ASLawrence H. Cohn, MD, Boston, MassPresidential
Perspectives
745 Historical perspectives of The American Association for Thoracic Surgery:
W. Gerald Austen
Cameron D. Wright, MD, Boston, MassAEditorial
748 Pulmonary metastasectomy for colorectal cancer: Making the case for
a randomized controlled trial in the zone of uncertaintyCDFrancesca Fiorentino, PhD, and Tom Treasure, MD, MS, FRCS, FRCP, London, United KingdomCH
DPulmonary metastasectomy is considered a routine treatment option in advanced colorectal
cancer, but accumulating observational evidence suggests that the selection criteria in current
practice includes patients who gain no benefit and the guidelines should be more restrictive.
This hypothesis is being tested by the randomized controlled Pulmonary Metastasectomy in
Colorectal Cancer trial.Cardiothoracic Surgical
Education and Training
(EDU)
753 Six-year integrated cardiothoracic surgery residency applicants:
Characteristics, expectations, and concerns
Vakhtang Tchantchaleishvili, MD, Bryan Barrus, MD, Peter A. Knight, MD, Carolyn E. Jones, MD,
Thomas J. Watson, MD, and George L. Hicks, MD, Rochester, NYTXCandidates interviewing for 6-year integrated cardiothoracic surgery residency programs for the
2012 match season were surveyed. The analysis of survey responses showed that most of these
candidates were young, high-achieving individuals oriented toward academic careers with
a significant interest in dedicated research time and cardiac surgery.759 Cardiothoracic surgery residency training: Past, present, and future
PMAra Asadur Vaporciyan, MD, Stephen C. Yang, MD, Craig J. Baker, MD, James I. Fann, MD, and
Edward D. Verrier, MD, Houston, Tex; Baltimore, Md; Los Angeles and Palo Alto, Calif; and
Seattle, WashThe rich traditions in cardiothoracic surgery training are changing. This review discusses historical
and environmental factors that influence the trainee, trainer, and the specialty in general because
such factors impact surgical education.) E
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712A The Journal of Thoracic an68 Local recurrence after surgery for non–small cell lung cancer: A recursive
partitioning analysis of multi-institutional data(continued on page 14A
d Cardiovascular Surgery c October 2013Chris R. Kelsey, MD, Kristin A. Higgins, MD, Bercedis L. Peterson, PhD, Junzo P. Chino, MD,
Lawrence B. Marks, MD, Thomas A. D’Amico, MD, and John M. Varlotto, MD, Durham and
Chapel Hill, NC; Atlanta, Ga; and Hershey, PaThe risk of local recurrence after surgery for lung cancer is high. Although standard clinical and
pathological risk factors for recurrence have been identified, they do not provide optimal
discrimination between low- and high-risk cohorts. More precise methods to assess risk are needed.774 Video-assisted mediastinoscopic lymphadenectomy is associated with better
survival thanmediastinoscopy in patientswith resectednon–small cell lung cancer
Akif Turna, MD, PhD, FETCS, Ahmet Demirkaya, MD, Serkan €Ozkul, MD, Buge Oz, MD,
Atilla Gurses, MD, and Kamil Kaynak, MD, FETCS, Istanbul, TurkeyWe aimed to analyze the impact of VAMLA on survival in resected patients with NSCLC.
Compared with conventional mediastinoscopy, VAMLA identified more N2 and N3 NSCLC and
was associated with better 5-year survival.781 Lymphatic invasion predicts survival in patients with early node-negative
non–small cell lung cancer
Michael F. Nentwich, MD, Benjamin A. Bohn, MD, Faik G. Uzunoglu, MD, Matthias Reeh, MD,
Alexander Quaas, MD, Tobias J. Grob, MD, PhD, Daniel Perez, MD, Asad Kutup, MD,
Maximilian Bockhorn, MD, Jakob R. Izbicki, MD, FACS, FRCS, and Yogesh K. Vashist, MD,
Hamburg, GermanyLymphatic invasion occurs in early tumor stages and is associated with poor survival. It should be
considered as a high-risk factor, and its implications as a selection criterion for possible adjuvant
therapies should be further analyzed.788 Prognostic factors after complete resection of pN2 non–small cell lung cancer
Makoto Sonobe, MD, PhD, Hiroshi Date, MD, PhD, Hiromi Wada, MD, PhD,
Kenichi Okubo, MD, PhD, Hiroshi Hamakawa, MD, PhD, Satoshi Teramukai, PhD,
Akihide Matsumura, MD, PhD, Tatuo Nakagawa, MD, PhD, Shin-ichi Sumitomo, MD, PhD,
Yoshihiro Miyamoto, MD, PhD, Norihito Okumura, MD, PhD, Sadanori Takeo, MD, PhD,
Kenzo Kawakami, MD, PhD, Minoru Aoki, MD, PhD, and Shinji Kosaka, MD, PhD,
The Japan-Multinational Trial Organization, Kyoto, Tokyo, Kobe, Sakai, Tenri, Wakayama, Himeji,
Kurashiki, Fukuoka, Moriyama, and Izumo, JapanPrognostic factors for patients with completely resected pN2 NSCLC included pT classification for
disease-free and overall survival, and tumor diameter, performance status, and sex for overall
survival. Single or multiple N2 metastases, skip or nonskip N2 metastasis, and extent of N2
metastasis also had prognostic value.796 Are discordant positron emission tomography and pathological assessments of
the mediastinum in non–small cell lung cancer significant?
Daniel J. Tandberg, BS, Nathan G. Gee, MD, Junzo P. Chino, MD, Thomas A. D’Amico, MD,
Neal E. Ready, MD, PhD, R. Edward Coleman, MD, and Chris R. Kelsey, MD, Durham, NCWe assessed the prognostic significance of discordant PET and pathologic assessments of the
mediastinum in NSCLC. Among 547 patients pathologically negative in the mediastinum, patients
with positive findings in the mediastinum on preoperative PET (n5 105) were at no higher risk of
disease recurrence or death compared with patients with a negative preoperative PET.)
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814A The Journal of Thoracic an02 Management of dilated ascending aorta during aortic valve replacement: Valve
replacement alone versus aorta wrapping versus aorta replacement(continued on page 16A
d Cardiovascular Surgery c October 2013Seung Hyun Lee, MD, Joon Bum Kim, MD, PhD, Dong Hee Kim, MD, Sung-Ho Jung, MD, PhD,
Suk Jung Choo, MD, PhD, Cheol Hyun Chung, MD, PhD, and Jae Won Lee, MD, PhD,
Seoul, KoreaConsecutive 499 patients undergoing aortic valve replacement in the presence of the ascending
aorta dilatation (40 to 55 mm) were evaluated. Compared with concomitant aortic wrapping or
replacement, valve replacement alone achieved similar clinical outcomes showing considerably
low risks of adverse aortic events or relevant aortic expansion.810 Should paroxysmal atrial fibrillation be treated during cardiac surgery?
Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN,
Adin-Cristian Andrei, PhD, Zhi Li, MS, Edwin C. McGee, Jr, MD, S. Chris Malaisrie, MD, and
Richard Lee, MD, MBA, Chicago, IllConcomitant ablation for PAF provides high late freedom from AF, and the midterm survival was
similar to that of the patients with no history of AF and better than those with untreated AF.824 Fractional flow reserve–guided coronary artery bypass grafting: Can
intraoperative physiologic imaging guide decision making?
T. Bruce Ferguson, Jr, MD, Cheng Chen, PhD, Joseph D. Babb, MD, Jimmy T. Efird, PhD,
Ramesh Daggubati, MD, and John M. Cahill, MD, Greenville, NCIntraoperative imaging with NIRF-CAPA can quantitatively differentiate between
angiographically patent bypass grafts that are and are not associated with an increase in
myocardial perfusion. These intraoperative imaging data could help guide and support
FFR-guided CABG.836 Edge-to-edge repair for prevention and treatment of mitral valve systolic
anterior motion
Patrick O. Myers, MD, Zain Khalpey, MD, PhD, Ann M. Maloney, Derek R. Brinster, MD,
Michael N. D’Ambra, MD, and Lawrence H. Cohn, MD, Boston, Mass, and Richmond, VaThe edge-to-edge technique has been proposed to manage systolic anterior motion of the
mitral valve after mitral valve repair. Our results suggest that the edge-to-edge technique
effectively treats systolic anterior motion and mitral regurgitation in patients with prerepair
echocardiographic predictors of systolic anterior motion or postrepair systolic anterior
motion.841 Isolated tricuspid valve surgery in patients with previous cardiac surgery
Bettina Pfannm€uller, MD, Monica Moz, MD, Martin Misfeld, MD, PhD,
Michael A. Borger, MD, PhD, Anne-Kathrin Funkat, PhD, Jens Garbade, MD, PhD, and
Friedrich W. Mohr, MD, PhD, Leipzig, GermanyFew studies have been published in literature on outcomes of isolated tricuspid valve surgery when
performed as a reoperation. Our analysis revealed that postoperative results of isolated tricuspid
valve surgery as a reoperation are acceptable when performed electively and that minimally
invasive surgery is a safe approach for these patients.)
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S816A The Journal of Thoracic an48 Increased plasma homocysteine predicts arrhythmia recurrence after
minimally invasive epicardial ablation for nonvalvular atrial fibrillation(continued on page 17A
d Cardiovascular Surgery c October 2013Giuseppe Nasso, MD, Raffaele Bonifazi, MD, Vito Romano, MD, Mario Siro Brigiani, MD,
Flavio Fiore, MD, Francesco Bartolomucci, MD, Mauro Lamarra, MD, Khalil Fattouch, MD,
Giuseppe Rosano, MD, Mario Gaudino, MD, Roberta Spirito, MD, Carlo Gaudio, MD, and
Giuseppe Speziale, MD, Bari, Andria, Cotignola, Palermo, and Rome, ItalySurgical minimally invasive ablation is an emerging treatment for lone atrial fibrillation. The
present study indicates that the circulating levels of homocysteine measured at the follow-up after
ablation reliably predict the risk of arrhythmia recurrence. Homocysteine may be used to refine the
criteria to indicate minimally invasive surgical ablation of atrial fibrillation.Congenital Heart
Disease (CHD)
854 Two-ventricle repairs in the unbalanced atrioventricular canal defect spectrum
with midterm follow-up
John E. Foker, MD, PhD, JamesM. Berry, RDMS, JeffreyM. Vinocur, MD, Brian A. Harvey, BA, and
Lee A. Pyles, MD, Minneapolis, MinnGrowth of hypoplastic ventricles and AV valves was induced in 23 consecutive patients with
unbalanced AV canal defects. When balance was established, the desirable 2-ventricle repair was
achieved in all, and 20 (87%) of 23 survived at midterm. Follow-up (5-19 years) revealed 15 (83%)
of 18 were taking no cardiac failure medications.861 Urinary biomarkers and renal near-infrared spectroscopy predict intensive
care unit outcomes after cardiac surgery in infants younger than 6 months of
age
Matthew A. Hazle, MD, Robert J. Gajarski, MD, Ranjit Aiyagari, MD, Sunkyung Yu, MS,
Abin Abraham, Janet Donohue, MPH, and Neal B. Blatt, MD, PhD, Ann Arbor, MichIn a prospective study of 49 infants with congenital heart disease, low levels of urinary biomarkers
within the first 2 hours after surgery can identify patients whowill have a good outcome. Renal near
infrared spectroscopy within the first 24 hours after surgery identifies those infants with good and
poor outcomes.868 22q11.2 Deletion syndrome is associated with perioperative outcome in
tetralogy of Fallot
Laura Mercer-Rosa, MD, MSCE, Nelangi Pinto, MD, Wei Yang, PhD, Ronn Tanel, MD, and
Elizabeth Goldmuntz, MD, Philadelphia, Pa, Salt Lake City, Utah, and San Francisco, CalifA retrospective study of 208 patients with tetralogy of Fallot found that patients with 22q11.2
deletion syndrome have more aortopulmonary shunts preceding surgical repair, longer
cardiopulmonary bypass time, and longer duration of intensive care. The study suggests that
22q11.2 deletion syndrome may affect early operative outcomes in tetralogy of Fallot.874 Modified Sakakibara classification system for ruptured sinus of Valsalva
aneurysm
Luo Xin-jin, MD, Li Xuan, MD, Peng Bo, MD, Guo Hong-wei, MD, Wang Wei, MD,
Li Shou-jun, MD, and Hu Sheng-shou, MD, Beijing, ChinaWe have proposed a modification of the Sakakibara classification system for RSVAs that we believe
will be clinically useful in determining a course of surgical therapy for these rare patients. We also
evaluated the associated cardiac lesions and approaches to surgical repair used for each type.)
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prosthetic heart valves(continued on page 18A
The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 4 17AED
UAjit P. Yoganathan, PhD, Mark Fogel, MD, Susan Gamble, BS, MBA, Michael Morton, MA,
Paul Schmidt, MS, Jeff Secunda, MS, MBA, Sara Vidmar, MBA, and Pedro del Nido, MD,
Atlanta, Ga, Philadelphia, Pa, Irvine, Calif, Minneapolis, Minn, Washington, DC, and
Boston, MassThis article provides recommendations on design approach, testing, and premarket and
postmarket clinical studies that should be considered by a heart valve manufacturer for obtaining
regulatory approval of pediatric sizes of prosthetic heart valve designs already approved for adult
clinical use.TSCommentary 887 Food and Drug Administration commentary on ‘‘A new paradigm for obtaining
marketing approval for pediatric-sized prosthetic heart valves’’GFernando Aguel, MSE, Steven B. Kurtzman, MD, Sonna Patel-Raman, PhD,
Matthew Hillebrenner, MSE, and Bram D. Zuckerman, MD, Silver Spring, MdACardiothoracic
Transplantation (TX)
888 Composite risk factors predict survival after transplantation for congenital
heart diseaseCDMinoo N. Kavarana,MD, Andrew Savage, MD, Robert O’Connell, BS, Catherine S. Rubinstein, NP,
Jennifer Flynn-Reeves, PA, Kishor Joshi, MBBS, Martha R. Stroud, MS, John S. Ikonomidis, MD,
and Scott M. Bradley, MD, Charleston, SCDComposite risk factors are better predictors of mortality than individual risk factors after heart
transplant for congenital heart disease.894 Comparative study of bronchial artery revascularization in lung
transplantationCHG€osta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas R. Johnston, MD,
Kenneth R. McCurry, MD, Samir R. Kapadia, MD, Marie M. Budev, DO, MPH,
Robin K. Avery, MD, David P. Mason, MD, Sudish C. Murthy, MD, PhD, and
Eugene H. Blackstone, MD, Cleveland, Ohio, and Baltimore, MdTXThis first comparative study of lung transplantation, with and without BAR, confirmed that BAR is
safe, with comparable early outcomes. Benefits of BAR include reduced airway ischemia and
complications, lower biopsy tissue grades, fewer infections, and delay of BOS. A multicenter study
is needed to establish these benefits.9
M01 Crossed wiring closure technique for bilateral transverse thoracosternotomy is
associated with less sternal dehiscence after bilateral sequential lung
transplantationPTheodoor D. Koster, MD, Faiz Z. Ramjankhan, MD, Ed A. van de Graaf, MD, PhD,
Bart Luijk, MD, PhD, Diana A. van Kessel, MD, Ronald C. A. Meijer, MD, and
Johanna M. Kwakkel-van Erp, MD, PhD, Utrecht and Nieuwegein, The Netherlands/B
SThe closure technique of the sternum in bilateral transverse thoracosternotomy after bilateral
sequential lung transplantation is associated with sternal dehiscence. The sternally crossed closure
technique reduces the incidence of sternal dehiscence compared with the uncrossed closure
technique.)
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918A The Journal of Thoracic an06 Prevention of postoperative atrial fibrillation in open heart surgery patients by
preoperative supplementation of n-3 polyunsaturated fatty acids: An updated
meta-analysis(continued on page 19A
d Cardiovascular Surgery c October 2013Simona Costanzo, MS, PhD, Veronica di Niro, BN, Augusto Di Castelnuovo, MS, PhD,
Francesco Gianfagna, MD, PhD, Maria Benedetta Donati, MD, PhD,
Giovanni de Gaetano, MD, PhD, and Licia Iacoviello, MD, PhD, Campobasso, ItalyThis updated meta-analysis of 8 randomized clinical trials shows a reduction averaging
16% (95% CI, 1%-29%) in postoperative atrial fibrillation after cardiac surgery by
preoperative n-3 polyunsaturated fatty acid supplementation. After isolated coronary artery
bypass graft surgery (7 studies), a significant protection of 34% was observed (95% CI,
13%-50%).912 Effect of adding postoperative noninvasive ventilation to usual care to prevent
pulmonary complications in patients undergoing coronary artery bypass
grafting: A randomized controlled trial
Emad Al Jaaly, MD, MRCS, Francesca Fiorentino, PhD, MSc, BSc,
Barnaby C. Reeves, MSc, DPhil, Philip W. Ind, MA, FRCP,
Gianni D. Angelini, MD, MCh, FRCS, FETCS, FMedSci, Scott Kemp, MBBS, BSc, FRCA, and
Robert J. Shiner, MRCS, FRCP, London, United KingdomIn a 2-group, parallel, randomized controlled trial, we compared the efficacy of NIV with BLPAP
added to usual care versus usual care alone in patients undergoing CABG. The use of BLPAP at
extubation reduced the recovery time by 1 day.919 Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting
postoperative atrial fibrillation after cardiac surgery
Su-Kiat Chua, MD, Kou-Gi Shyu, MD, PhD, Ming-Jen Lu, MD, Li-Ming Lien, MD, PhD,
Chia-Hsun Lin, MD, Hung-Hsing Chao, MD, PhD, and Huey-Ming Lo, MD, Taipei, TaiwanThis study aims to investigate whether the CHADS2 and CHA2DS2-VASc scores are useful risk
assessment tools for new-onset POAF after cardiac surgery. Of 277 consecutive patients, 84 (30%)
had POAF. The CHADS2 and CHA2DS2-VASc scores were significant predictors of POAF in
separate multivariate regression analyses.927 Efficacy and safety of recombinant factor XIII on reducing blood transfusions
in cardiac surgery: A randomized, placebo-controlled, multicenter clinical trial
Keyvan Karkouti, MD, Christian von Heymann, MD, Christian M. Jespersen, MD,
Wolfgang Korte, MD, Jerrold H. Levy, MD, Marco Ranucci, MD, Frank W. Sellke, MD, and
Howard K. Song, MD, PhD, Toronto, Ontario, Canada; Berlin, Germany; Bagsværd, Denmark;
St Gallen, Switzerland; Atlanta, Ga; San Donato Milanese (Milan), Italy; Providence, RI; and
Portland, OreLow factor XIII levels may contribute to excessive bleeding and blood product transfusion after
cardiac surgery, suggesting that replenishment of factor XIII may reduce transfusion needs.
Recombinant factor XIII administered after cardiopulmonary bypass safely restored factor XIII
activity but did not affect transfusion requirements in cardiac surgery patients.)
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940 Protecting the aged heart during cardiac surgery: Use of del Nido cardioplegia
provides superior functional recovery in isolated hearts(continued on page 20A
The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 4 19AUArun Govindapillai, BSc, Rui Hua, PhD, Robert Rose, PhD, Camille Hancock Friesen, MD, and
Stacy B. O’Blenes, MD, Halifax, Nova Scotia, CanadaEDAn isolated working heart model was used to determine if del Nido cardioplegia provides better
myocardial protection than standard cardioplegia for elderly hearts. Fewer hearts protected with del
Nido cardioplegia had spontaneous activity during arrest, and troponin release was reduced.
Functional recovery was superior in isolated aged hearts arrested with del Nido cardioplegia.9TS49 BRCA1 is a novel target to improve endothelial dysfunction and retard
atherosclerosisGKrishna K. Singh, PhD, Praphulla C. Shukla, PhD, Adrian Quan, MPhil,
Mohammed Al-Omran, MD, MSc, FRCSC, Fina Lovren, PhD, Yi Pan, MD,
Christine Brezden-Masley, MD, PhD, FRCPC, Alistair J. Ingram, MD, William L. Stanford, PhD,
Hwee Teoh, PhD, and Subodh Verma, MD, PhD, FRCSC, Toronto, Hamilton, and Ottawa, Ontario,
Canada; and Riyadh, Kingdom of Saudi ArabiaD
A
CBRCA1 critically regulates genome-wide stability primarily through promotion of DNA damage
repair. We explored the potential role of BRCA1 in the regulation of endothelial function and
atherosclerosis. We demonstrate that BRCA1 protects endothelial cells against inflammation- and
genotoxic stress–induced endothelial dysfunction and that BRCA1-based gene therapy retards
experimental atherosclerosis.9CH
D61 Hot shot induction and reperfusion with a specific blocker of the es-ENT1
nucleoside transporter before and after hypothermic cardioplegia abolishes
myocardial stunning in acutely ischemic hearts despite metabolic
derangement: Hot shot drug delivery before hypothermic cardioplegia
Anwar Saad Abd-Elfattah, PhD, Gert E. Tuchy, MD, Michael E. Jessen, MD, David R. Salter, MD,
Jacques P. Goldstein, MD, PhD, Louis A. Brunsting III, MD, and Andrew S. Wechsler, MD,
Richmond, Va, Dallas, Tex, Brussels, Belgium, Nashville, Tenn, and Philadelphia, PaTXInduction of antegrade or retrograde hypothermic cardioplegia into ischemic hearts releases purines
via the es-ENT1 nucleoside transporter until the hearts are cold. Reperfusion forces release and
conversion of cold-entrapped purines to free radical substrates. A hot shot and reperfusion with
a selective nucleoside transport blocker abolished myocardial stunning despite prolonged cold
cardioplegic arrest.971 Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/
CD34-positive endothelial cells in a hindlimb ischemia model: Implications for
angiogenesis and vasculogenesisPM
Can Tepek€oyl€u, MD, Feng-Sheng Wang, PhD, Radoslaw Kozaryn, MS,
Karin Albrecht-Schgoer, PhD, Markus Theurl, MD, Wolfgang Schaden, MD, Huei-Jin Ke,
Yaju Yang, Rudolf Kirchmair, MD, Michael Grimm, MD, Ching-Jen Wang, MD, and
Johannes Holfeld, MD, Innsbruck and Vienna, Austria; and Kaohsiung, TaiwanSSWT enhanced the expression of angiogenic cytokines and chemoattractants for mobilization of
EPCs in hind limb ischemia in rats. We consistently found increased numbers of circulating EPCs
and induction of angiogenesis. Blood perfusion increased significantly and led to functional
restoration of ischemic muscle.)
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SCardiothoracic Imaging 920A The Journal of Thoracic an79 Use of video-assisted thoracoscopic surgery in penetrating chest trauma(continued on page 21A
d Cardiovascular Surgery c October 2013Laura L. Stafman, BA, Luke G. Gutwein, MD, andDarwin N. Ang,MD, PhD,MPH, Gainesville and
Tampa, Fla980 Pulmonary artery obstruction caused by a rare type of primary cardiac
synovial sarcoma
Qiuzhe Guo, MD, Chunyan Lu, MD, and Yingqiang Guo, MD, Chengdu, Sichuan, ChinaSurgical Techniques 981 Continuous-flow left ventricular assist device implantation in the presence of
a hostile ventricular apex
Pavan Atluri, MD, Daniel J. Dymond, PA-C, and Y. Joseph Woo, MD, Philadelphia, Pa983 Recurrent sustained ventricular tachycardia, hypertrophic cardiomyopathy,
and apical aneurysm: Electroanatomic map–guided surgical ablation and left
ventricular restoration
Kazuya Kobayashi, MD, Toshihiro Ohata, MD, PhD, Hideki Ueda, MD, PhD, and
Kenjiro Miyamoto, MD, Sapporo, JapanBrief Research Reports 986 The role of surgical procedures on discriminative performance of the updated
euroSCORE II
Fabio Barili, MD, PhD, Davide Pacini, MD, Francesco Rosato, MD, and
Alessandro Parolari, MD, PhD, Cuneo, Bologna, and Milan, Italy987 Single-lung transplants: The fate of the second donor lung
Anne Olland, MSc, MD, Pierre-Emmanuel Falcoz, MD, PhD, FETS, Nicola Santelmo, MD, and
Gilbert Massard, MD, PhD, FETS, Strasbourg, FranceOnline Only:
Case Reports
e21 Starr–Edwards aortic valve: Forty-four years old and still working!
Pankaj Saxena, FRACS, PhD, Crystal R. Bonnichsen, MD, and Kevin L. Greason, MD,
Rochester, Minne22 A complicated case of Carney complex: Fifth reoperative cardiac surgery for
resection of recurrent cardiac myxoma
Manuel Wilbring, MD, Stephan Wiedemann, MD, Utz Kappert, MD, and Klaus Matschke, MD,
Dresden, Germanye24 Initial experience of transcatheter aortic valve replacement with the St Jude
Medical Portico valve inserted through the transapical approach
Marina Urena, MD, Daniel Doyle, MD, Josep Rodes-Cabau, MD, and Eric Dumont, MD, Quebec
City, Quebec, Canadae27 Sutureless aortic valve replacement in the presence of a mechanical mitral
prosthesis
Amine Mazine, MD, Tam Hoang Minh, MD, Denis Bouchard, MD, FRCSC, and
Philippe Demers, MD, FRCSC, Montreal, Quebec, Canadae29 Long-term biventricular support with rotary blood pumps in a patient with
a noncontractile heart
Taichi Sakaguchi, MD, Shunsuke Saito, MD, Daisuke Yoshioka, MD, and Yoshiki Sawa, MD,
Osaka, Japan)
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The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 4 21AKarine Nubret, MD, Philippe Mauriat, MD, Franc¸ois Roubertie, MD, Chloe James, MD,
Nadir Tafer, MD, and Alexandre Ouattara, MD, PhD, Bordeaux and Pessac, FranceUe33 Port-access redo mitral valve surgery in a 13-year-old child EDDavide Ricci, MD, Cristina Barbero, MD, Massimo Boffini, MD, Suad El Qarra, MD,
Francesca Ivaldi, MD, Luca Deorsola, MD, Carlo Pace, MD, and Mauro Rinaldi, MD, Turin and
Pavia, Italye35 Endoscopic lung abscess drainage with argon plasma coagulation
Eric Goudie, MD, Jordan Kazakov, MD, Claude Poirier, MD, and Moishe Liberman, MD, PhD, STMontreal, Quebec, Canada Ge37 Chest wall reconstruction after resection of a chest wall sarcoma by
osteosynthesis with the titanium MatrixRIB (Synthes) system
L. Marleen Boerma, MD, Mike Bemelman, MD, and Thijs van Dalen, MD, PhD, Utrecht,
The NetherlandseA
C40 Transapical aortic valve (JenaValve) implantation for severe aortic
insufficiency and aortic aneurysmDFriederike Schlingloff, MD, Christian Frerker, MD, Ulrich Sch€afer, MD, and Ralf Bader, MD,
Hamburg, Germanye42 Paracorporeal lung assist device: An innovative surgical strategy for bridging
to lung transplant in an infant with severe pulmonary hypertension caused by
alveolar capillary dysplasiaD
CHUmar S. Boston, MD, James Fehr, MD, Avihu Z. Gazit, MD, and Pirooz Eghtesady, MD, PhD,
St Louis, MoLetters to the Editor 990 The dog didn’t bark
Vincent Acton, FRANZCR, Sydney, Australia990 Reply to the EditorTXMariette Baud, MD, Patricia Forgez, PhD, Diane Damotte, MD, PhD, and
Marco Alifano, MD, PhD, Paris, France991 Supplementation of N-3 polyunsaturated fatty acids to prevent postoperative
atrial fibrillation in patients subjected to heart surgery
Andrea Messori, PharmD, Valeria Fadda, PharmD, and Dario Maratea, PharmD, Firenze, Italy992 Reply to the Editor
PMSimona Costanzo, MS, PhD, Augusto Di Castelnuovo, MS, PhD, and Licia Iacoviello, MD, PhD,
Campobasso, Italy993 Response to staged percutaneous coronary intervention andminimally invasive
valve surgery: Results of a hybrid approach to concomitant coronary and
valvular disease
Orlando Santana, MD, and Joseph Lamelas, MD, Miami Beach, Fla)
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Supplemental material is available online
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